FENNEC PHARMACEUTICALS INC. (FENC)
Data as of , from SEC Form 4 filings.
See up to 3 months of FENC. The 7-day demo opens the 1M and 3M ranges and puts FENC on your watchlist.
Start 7-day demoLatest FENC insider trades
About FENNEC PHARMACEUTICALS INC. (FENC)
FENNEC PHARMACEUTICALS INC. files with the SEC under CIK 0001211583 and is classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
FENC Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 5 | 122,545 | $1.41M |
| Grant or award | 22 | 31,806 | |
| Option exercise | 4 | 74,946 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
FENC insider transactions (Form 4)
63128 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Christiana Marie Cioffi - Officer | Grant or award | Common shares | 156 | $0.00 | - | |
| Marco Maria Brughera | Grant or award | Stock Option | 20,000 | $8.70 | $174K | |
| Jodi A. Cook | Grant or award | Stock Options | 20,000 | $8.70 | $174K | |
| Khalid Islam | Grant or award | Stock Option | 25,000 | $8.70 | $217K | |
| Chris A. Rallis | Grant or award | Stock Option | 20,000 | $8.70 | $174K | |
| Rosty Raykov | Grant or award | Common shares | 2,778 | $0.00 | - | |
| Rosty Raykov | Option exercise | Common shares | 15,597 | $2.45 | $38K | |
| Rosty Raykov | Open-market sale | Common shares | 9,747 | $9.62 | $94K | |
| Rosty Raykov | Option exercise | Stock Options | 15,597 | $2.45 | $38K | |
| Christiana Marie Cioffi - Officer | Grant or award | Common shares | 156 | $0.00 | - | |
| Terry L. Evans - Officer | Grant or award | Common Shares | 168 | $0.00 | - | |
| Pierre Sargis Sayad - Officer | Grant or award | Common Shares | 168 | $0.00 | - | |
| Jeffrey S. Hackman - Officer | Grant or award | Common Shares | 1,159 | $0.00 | - | |
| Robert Andrade - Officer | Grant or award | Common shares | 1,703 | $0.00 | - | |
| Chris A. Rallis | Option exercise | Common Shares | 14,344 | $2.44 | $35K | |
| Chris A. Rallis | Open-market sale | Common Shares | 8,346 | $7.04 | $59K | |
| Chris A. Rallis | Option exercise | Stock Option | 14,344 | $2.44 | $35K | |
| Rosty Raykov | Option exercise | Common shares | 2,778 | $0.00 | - | |
| Rosty Raykov | Option exercise | Common shares | 15,598 | $2.45 | $38K | |
| Rosty Raykov | Open-market sale | Common shares | 10,781 | $6.47 | $70K | |
| Rosty Raykov | Option exercise | Stock Options | 15,598 | $2.45 | $38K | |
| Terry L. Evans - Officer | Option exercise | Common Shares | 168 | $0.00 | - | |
| Christiana Marie Cioffi - Officer | Option exercise | Common shares | 155 | $0.00 | - | |
| Jeffrey S. Hackman - Officer | Option exercise | Common Shares | 1,159 | $0.00 | - | |
| Robert Andrade - Officer | Option exercise | Common shares | 1,703 | $0.00 | - | |
| Pierre Sargis Sayad - Officer | Option exercise | Common Shares | 168 | $0.00 | - | |
| Christiana Marie Cioffi - Officer | Option exercise | Common shares | 17,106 | $0.00 | - | |
| Christiana Marie Cioffi - Officer | Option exercise | Common shares | 158 | $0.00 | - | |
| Christiana Marie Cioffi - Officer | Option exercise | Common shares | 1,901 | $0.00 | - | |
| Christiana Marie Cioffi - Officer | Grant or award | Stock Options | 120,000 | $5.77 | $692K | |
| Jeffrey S. Hackman - Officer | Option exercise | Common Shares | 16,695 | $0.00 | - | |
| Jeffrey S. Hackman - Officer | Option exercise | Common Shares | 1,159 | $0.00 | - | |
| Jeffrey S. Hackman - Officer | Option exercise | Common Shares | 13,943 | $0.00 | - | |
| Jeffrey S. Hackman - Officer | Grant or award | Stock Options | 200,000 | $5.77 | $1.15M | |
| Rosty Raykov | Grant or award | Common shares | 5,208 | $0.00 | - | |
| Rosty Raykov | Option exercise | Common shares | 15,598 | $2.45 | $38K | |
| Rosty Raykov | Open-market sale | Common shares | 10,946 | $6.31 | $69K | |
| Rosty Raykov | Option exercise | Stock Options | 15,598 | $2.45 | $38K | |
| Pierre Sargis Sayad - Officer | Option exercise | Common Shares | 18,456 | $0.00 | - | |
| Pierre Sargis Sayad - Officer | Option exercise | Common shares | 171 | $0.00 | - | |
| Pierre Sargis Sayad - Officer | Option exercise | Common shares | 2,052 | $0.00 | - | |
| Pierre Sargis Sayad - Officer | Grant or award | Stock Options | 120,000 | $5.77 | $692K | |
| Robert Andrade - Officer | Option exercise | Common shares | 14,724 | $0.00 | - | |
| Robert Andrade - Officer | Option exercise | Common shares | 2,213 | $0.00 | - | |
| Robert Andrade - Officer | Option exercise | Common shares | 12,270 | $0.00 | - | |
| Robert Andrade - Officer | Grant or award | Stock Options | 120,000 | $5.77 | $692K | |
| Terry L. Evans - Officer | Option exercise | Common Shares | 18,456 | $0.00 | - | |
| Terry L. Evans - Officer | Option exercise | Common shares | 171 | $0.00 | - | |
| Terry L. Evans - Officer | Option exercise | Common shares | 2,052 | $0.00 | - | |
| Terry L. Evans - Officer | Grant or award | Stock Options | 120,000 | $5.77 | $692K | |
| Robert Andrade - Officer | Option exercise | Common shares | 13,072 | $5.10 | $67K | |
| Robert Andrade - Officer | Option exercise | Stock Options | 13,072 | $5.10 | $67K | |
| Christiana Marie Cioffi - Officer | Option exercise | Common shares | 4,700 | $4.23 | $20K | |
| Christiana Marie Cioffi - Officer | Option exercise | Stock Options | 4,700 | $4.23 | $20K | |
| Robert Andrade - Officer | Grant or award | Common shares | 1,191 | $0.00 | - | |
| Rosty Raykov | Option exercise | Common shares | 15,598 | $2.45 | $38K | |
| Rosty Raykov | Open-market sale | Common shares | 10,079 | $8.36 | $84K | |
| Rosty Raykov | Grant or award | Common shares | 5,208 | $0.00 | - | |
| Rosty Raykov | Option exercise | Stock Options | 15,598 | $2.45 | $38K | |
| Jeffrey S. Hackman - Officer | Option exercise | Common Shares | 13,710 | $0.00 | - | |
| Robert Andrade - Officer | Option exercise | Common shares | 2,450 | $4.08 | $10K | |
| Robert Andrade - Officer | Option exercise | Common shares | 27,285 | $0.00 | - | |
| Robert Andrade - Officer | Option exercise | Stock Options | 2,450 | $4.08 | $10K |
Recent FENC Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| MARCO BRUGHERA | Director | 15,545 | $160K | View on EDGAR | |
| ROSTISLAV RAYKOV | Former Director | 10,000 |
FENC insider trading FAQ
What is the latest insider trade for FENC?
FENNEC PHARMACEUTICALS INC. (FENC) had 25 insider filings in the last 90 days, with the most recent on 2026-10-13. The full record for FENC runs to 128 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying FENC stock?
No insider purchases of FENC were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling FENC stock?
5 insider sales of FENC were filed in the last 90 days, totaling $1.41M.
Where can I see FENC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects FENC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Pierre Sargis Sayad view on EDGAR
- - Jeffrey S. Hackman view on EDGAR
- - Terry L. Evans view on EDGAR
- - Christiana Marie Cioffi view on EDGAR
- - Robert Andrade view on EDGAR
- - Pierre Sargis Sayad view on EDGAR
- - Terry L. Evans view on EDGAR
- - Jeffrey S. Hackman view on EDGAR
- - Christiana Marie Cioffi view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where FENC's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow FENC with a 7-day demo
- FENC on your watchlist
- Every FENC Form 4 filing on record
- Up to 3 months of FENC price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
